Evidence map›Paper›PMID 42558913›Full record

ArticleHealth science reports2026

Rationale and Methods of a Surveillance System for Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies: A Qualitative Participatory Action Research Approach in Middle-Income Countries-The Experience in Iran.

Sima Oshnouei, Mohamad Jebraeily, Mohsen Asadi-Lari, Babak Eshrati, Rahim Asghari, Masoumeh Nabivandrezaei, Ali Arash Anoushirvani, Aarefeh Jafarzadeh-Kohneloo

Abstract read
In one paragraph

Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sima OshnoueiDepartment of Epidemiology, School of Public Health Iran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0009-0006-8953-3146
Mohamad JebraeilyDepartment of Health Information Technology, School of Allied Medical Sciences Urmia University of Medical Sciences Urmia Iran.ORCID https://orcid.org/0000-0001-7123-9252
Mohsen Asadi-LariDepartment of Epidemiology, School of Public Health, Oncopathology Research Center Iran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0001-6778-8750
Babak EshratiPreventive Medicine and Public Health Research Center, Psychosocial Health Research Institute Iran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0001-5999-7173
Rahim AsghariDepartment of Internal Medicine, School of Medicine Imam Khomeini Hospital, Urmia University of Medical Sciences Urmia Iran.ORCID https://orcid.org/0000-0002-7174-6446
Masoumeh NabivandrezaeiImam Khomeini Hospital Urmia University of Medical Sciences Urmia Iran.ORCID https://orcid.org/0009-0002-5956-8066
Ali Arash AnoushirvaniDepartment of Internal Medicine, School of Medicine, Firoozgar General Hospital Iran University of Medical Sciences Tehran Iran.
Aarefeh Jafarzadeh-KohnelooDepartment of Epidemiology and Biostatistics, School of Health Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0000-0002-2860-2420

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Hematopoietic Stem Cell Transplantation (HSCT) represents a cornerstone in the therapeutic management of hematological malignancies, aimed at achieving durable remission and enhancing survival. Optimal post-transplant care, however, necessitates access to near-real-time, actionable clinical data. Iran currently lacks a dedicated national surveillance framework for HSCT recipients. This study aims to develop and pilot a comprehensive surveillance system tailored to the complexities of HSCT within the Iranian healthcare context. Methods: This qualitative Participatory Action Research (PAR) study was conducted at a tertiary HSCT center in Iran (2024-2025). Using purposive sampling, 15 stakeholders (hematologists, nurses, informaticians, and registry experts) with 5 years of experience were recruited. Data comprised 46 iterative, semi-structured interviews (face-to-face and telephone) conducted until data saturation was reached. Thematic analysis with independent double coding and triangulation (methodological, data source, and theoretical triangulation against EBMT/CIBMTR standards) ensured credibility. A pilot phase tested feasibility, followed by iterative refinement based on stakeholder feedback prior to institutional integration. Results: Qualitative synthesis identified three pivotal domains for establishing a national HSCT surveillance system: transplant-specific clinical challenges, systemic barriers to development, and essential implementation phases. Primary impediments included regulatory and policy gaps, acute resource constraints, and technological deficits. Key developmental steps involved the standardization of case definitions, the design of robust data acquisition protocols, and the selection of evidence-based performance indicators. The pilot implementation highlighted critical operational hurdles, such as increased clinician workload and data entry burdens, which subsequently informed the development of tailored technical and structural solutions for the hospital-based rollout. Conclusions: This study provides a replicable methodological roadmap for establishing standardized HSCT monitoring systems in middle-income countries. By identifying longitudinal data gaps and treatment deficiencies, this framework fosters multi-level collaboration with policymakers and advocates for evidence-based clinical practices to ultimately improve patient outcomes.

Indexed as

hematological malignancieshematopoietic stem cell transplantationmiddle‐income countriesparticipatory action researchsurveillance development

Identifiers

PMID42558913
PMCPMC13438887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.